Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
9.28M
-
Shares change
-
+220K
-
Total reported value, excl. options
-
$54.5M
-
Value change
-
+$1.36M
-
Number of buys
-
20
-
Number of sells
-
-10
-
Price
-
$5.87
Significant Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q1 2021
40 filings reported holding SMMT - Summit Therapeutics Inc. - COM as of Q1 2021.
Summit Therapeutics Inc. - COM (SMMT) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.28M shares
.
Largest 10 shareholders include Polar Capital Holdings Plc (6.16M shares), BlackRock Inc. (747K shares), VANGUARD GROUP INC (550K shares), BAILLIE GIFFORD & CO (372K shares), MILLENNIUM MANAGEMENT LLC (346K shares), MORGAN STANLEY (215K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (134K shares), UBS Group AG (126K shares), ExodusPoint Capital Management, LP (93.5K shares), and GOLDMAN SACHS GROUP INC (86.5K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.